Chapter 56. Chapter 56. Future Therapies for Osteoporosis

  1. ASBMR
  1. Kong Wah Ng1,2,3 and
  2. T. John Martin2,3

Published Online: 23 DEC 2009

DOI: 10.1002/9780470623992.ch56

Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism

Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism

How to Cite

ASBMR (2008) Chapter 56. Future Therapies for Osteoporosis, in Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9780470623992.ch56

Author Information

  1. 1

    Department of Endocrinology and Diabetes. St. Vincent's Health, Melbourne, Australia

  2. 2

    St. Vincent's Institute, Melbourne, Australia

  3. 3

    University of Melbourne Department of Medicine, Victoria, Australia

Publication History

  1. Published Online: 23 DEC 2009
  2. Published Print: 18 NOV 2008

ISBN Information

Print ISBN: 9780977888214

Online ISBN: 9780470623992

SEARCH

Keywords:

  • cathepsin K inhibition;
  • integrin receptor inhibition;
  • chloride-7 channel inhibition;
  • Wnt signaling pathway;
  • sclerostin;
  • DKK- 1;
  • glycogen synthase kinase

Summary

This chapter contains sections titled:

  • Introduction

  • Antiresorptives

  • Anabolic Agents

  • Conclusion